Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells
In-Young Jung, Yoon-Young Kim, Ho-Sung Yu, et al.
Cancer Research (2018) Vol. 78, Iss. 16, pp. 4692-4703
Open Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong, Justin Clubb, Yvonne Y. Chen
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 473-488
Open Access | Times Cited: 486
CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 339
Noncoding RNAs in cancer therapy resistance and targeted drug development
Wentao Wang, Cai Han, Yu-Meng Sun, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 233
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
Alexander Dimitri, Friederike Herbst, Joseph A. Fraietta
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 220
Cell-Type-Specific CRISPR/Cas9 Delivery by Biomimetic Metal Organic Frameworks
Mram Alyami, Shahad K. Alsaiari, Yanyan Li, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 4, pp. 1715-1720
Open Access | Times Cited: 198
Cellular networks controlling T cell persistence in adoptive cell therapy
Jack D. Chan, Junyun Lai, Clare Y. Slaney, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 769-784
Closed Access | Times Cited: 162
Enhanced safety and efficacy of protease-regulated CAR-T cell receptors
Louai Labanieh, Robbie G. Majzner, Dorota D. Klysz, et al.
Cell (2022) Vol. 185, Iss. 10, pp. 1745-1763.e22
Open Access | Times Cited: 149
Next-Generation CAR T-cell Therapies
Regina M. Young, Nils W. Engel, Uğur Uslu, et al.
Cancer Discovery (2022) Vol. 12, Iss. 7, pp. 1625-1633
Open Access | Times Cited: 125
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Ehsan Razeghian, Mahyuddin K. M. Nasution, Heshu Sulaiman Rahman, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 117
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 102
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6273-6290
Open Access | Times Cited: 87
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
Zaoqu Liu, Meixin Shi, Yuqing Ren, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Metabolic challenges and interventions in CAR T cell therapy
Jhan-Jie Peng, Limei Wang, Zhiyu Li, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Closed Access | Times Cited: 59
Forks in the road for CAR T and CAR NK cell cancer therapies
Oula K. Dagher, Avery D. Posey
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 1994-2007
Closed Access | Times Cited: 57
Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
Ruiyu Tao, Xiaopeng Han, Xue Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 31
Unlocking the potential of engineered immune cell therapy for solid tumors
Víctor Albarrán, Laura Angelats, Julio Delgado, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Gene modification strategies for next-generation CAR T cells against solid cancers
Yonggui Tian, Yilu Li, Yupei Shao, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 129
Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities
Xiaotao Jiang, Xu Jiang, Mingfeng Liu, et al.
Cancer Letters (2019) Vol. 462, pp. 23-32
Closed Access | Times Cited: 110
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
Bas Weenink, Pim J. French, Peter A.E. Sillevis Smitt, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 751-751
Open Access | Times Cited: 87
Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease
Martijn P. T. Ernst, Mike Broeders, Pablo Herrero-Hernandez, et al.
Molecular Therapy — Methods & Clinical Development (2020) Vol. 18, pp. 532-557
Open Access | Times Cited: 80
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Sasan Ghaffari, Nastaran Khalili, Nima Rezaei
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 72
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
Ella Atsavapranee, Margaret M. Billingsley, Michael J. Mitchell
EBioMedicine (2021) Vol. 67, pp. 103354-103354
Open Access | Times Cited: 69
Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
Meng Zhang, Xin Jin, Rui Sun, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 56
Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity
Mariana Cooke, Marcelo G. Kazanietz
Science Signaling (2022) Vol. 15, Iss. 729
Closed Access | Times Cited: 50
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells
Tatsuki Ueda, Sara Shiina, Shoichi Iriguchi, et al.
Nature Biomedical Engineering (2022)
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top